NCT05748340

Brief Summary

Our study findings show that vertical lip length and philtral lip height significantly longer in Millard group than Mishra group in immediate postoperative assessment and nasal width was significantly wider in Mishra group than Millard in 3-month postoperative assessment, This may be attributed to that Mishra group deformity was more severe. The lip shape, the vermilion shape was better in Millard technique than Mishra technique, however, this was statistically insignificant The scar shape was less evident in Mishra technique than Millard technique. But this was also statistically insignificant. However, no major difference in the overall results between the Mishra and Millard rotationadvancement repairs. Thus, either technique could be used for unilateral clefts, as the goal of cleft lip repair is making a symmetrical lip with minimal scar restoring the normal appearance of the face and functional anatomy Anthropometric Measurement of surgical outcome evaluates the surgical technique used and helps to compare between cleft and non-cleft side showing the degree of deformity and we used Subjective assessment to analyse facial aesthetics and appearance impairment as the harmony of a person's face is as Important as measurements, so they should be used together in our opinion.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
42

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2021

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2022

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

February 16, 2023

Completed
12 days until next milestone

First Posted

Study publicly available on registry

February 28, 2023

Completed
Last Updated

February 28, 2023

Status Verified

February 1, 2023

Enrollment Period

1.4 years

First QC Date

February 16, 2023

Last Update Submit

February 25, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Surgical repair unilateral cleft lip measurements

    1. Vertical lip height 2. Horizontal lip length 3. Philtral length

    At 3 months post operative

Study Arms (3)

Control group

OTHER

21normal infant aged 3-6 months

Procedure: Unilateral cleft lip repair

Group a

OTHER

21 patient of unilateral cleft lip had mishra technique repair

Procedure: Unilateral cleft lip repair

Group b

OTHER

21 patient of unilateral cleft lip had modified Millard technique repair

Procedure: Unilateral cleft lip repair

Interventions

Surgical repair unilateral cleft lip

Control groupGroup aGroup b

Eligibility Criteria

Age3 Months - 6 Months
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Infants with unilateral isolated cleft lip aged from 2-6 months
  • Infants with incomplete and complete unilateral cleft lip(reach floor of the nose)

You may not qualify if:

  • Infants less than 2 months or more than 6 months
  • Bilateral cleft lip patients
  • Recurrent repair cleft lip cases
  • Facial cleft cases 5-Syndromic patients cases

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of medicine Cairo university

Giza, Cairo Governorate, 11074, Egypt

Location

MeSH Terms

Conditions

Cleft Lip

Condition Hierarchy (Ancestors)

Lip DiseasesMouth DiseasesStomatognathic DiseasesMouth AbnormalitiesStomatognathic System AbnormalitiesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Officials

  • Kasr Elainy

    Cairo university Egypt

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer pediatric surgery

Study Record Dates

First Submitted

February 16, 2023

First Posted

February 28, 2023

Study Start

April 1, 2021

Primary Completion

September 1, 2022

Study Completion

September 1, 2022

Last Updated

February 28, 2023

Record last verified: 2023-02

Data Sharing

IPD Sharing
Will share

Shared for every one

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
Time Frame
Once publication
Access Criteria
Open for every one

Locations